Market Forecast By Type (Pharmaceutical Drugs, Biologics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And Competitive Landscape
Product Code: ETC338488 | Publication Date: Aug 2022 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
Report Name | Indonesia Pharmaceuticals Market |
Forecast period | 2025-2031 |
CAGR | 5.4% |
Growing Sector | Healthcare |
The Indonesia Pharmaceutical Market Report covers thoroughly market by type, distribution channel, route of administration, drug classification, and mode of purchase. The Indonesia Pharmaceutical Market Report provides a detailed analysis of the ongoing trends in the Indonesian Pharmaceutical Market, Big Players in the Market and market drivers, Covid-19 impact on the market and Future Insights. This would help the stakeholders devise and align their market strategies according to the current and future market dynamics.
Indonesia Pharmaceutical Market has been accomplishing major success and is estimated to grow more. Indonesia is the fourth most populous country in the world and due to this, the Indonesian Pharmaceutical market has an estimated share of 8% on the global level and the Pharmaceutical market has grown rapidly over the last few years due to an increase in the rate of diseases like hypertension, diabetes, and chronic heart diseases.
According to 6Wresearch, Indonesia Pharmaceutical Market size is anticipated to grow at a CAGR of 8.6% during 2025-2031. Over the past decade, the pharmaceutical industry in Indonesia has experienced rapid growth, the Indonesian pharmaceuticals market is projected to grow significantly due to several key factors. The country’s large population, the increased purchasing power of the customers, increasing healthcare awareness, and expanding healthcare infrastructure are the factors responsible for the increase in demand for pharmaceutical products. Additionally, initiatives on improving access to healthcare by the government have also resulted in market growth. the advancements in research and technology and the increased in the facility are expected to drive the development of pharmaceutical solutions.
The pharmaceutical market in Indonesia has been growing rapidly due to the country`s large population and healthcare needs. Key players include PT Kalbe Farma Tbk, PT Tempo Scan Pacific Tbk, and PT Kimia Farma Tbk and some multinational companies like GlaxoSmithKline, Pfizer, Merck etc.
The Indonesian pharmaceutical industry plays a crucial role in providing affordable and accessible healthcare to the population. The government recognizes this and has implemented various initiatives to support the growth and development of the sector. One of the key initiatives is the establishment of the National Pharmaceutical Industry Development Program (P3N) in 2006. This program aims to strengthen local production capabilities, increase competitiveness, and reduce the country's dependency on imported pharmaceutical products. The P3N also provides various incentives such as tax breaks, loans, and subsidies to encourage investment in the industry.
Indonesian Pharmaceutical market is witnessing significant growth due to various factors such as population growth, government initiatives, technological advancements, and increasing awareness among the people. With the continuous innovation and efforts from key players in the industry, it is expected to further expand in the coming years.
According to Sachin, Research Analyst, 6Wresearch, pharmaceutical drugs have been the largest segment in the Indonesian pharmaceutical industry, accounting for more than 60% of total sales. This segment includes both patented and generic medicines used to treat various diseases and conditions. The demand for pharmaceutical drugs is expected to continue increasing due to the rising prevalence of chronic diseases and lifestyle-related illnesses in Indonesia.
Hospital pharmacies are considered to be one of the most important distribution channels in the pharmaceutical industry, as they cater to a wide range of patients and provide essential medications for various health conditions. They also play a vital role in managing inventory levels and ensuring timely delivery of products to healthcare facilities.
The report provides a detailed analysis of the following market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Pharmaceuticals Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Pharmaceuticals Market - Industry Life Cycle |
3.4 Indonesia Pharmaceuticals Market - Porter's Five Forces |
3.5 Indonesia Pharmaceuticals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Indonesia Pharmaceuticals Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 Indonesia Pharmaceuticals Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Indonesia Pharmaceuticals Market Revenues & Volume Share, By Drug Classification, 2021 & 2031F |
3.9 Indonesia Pharmaceuticals Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
4 Indonesia Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Pharmaceuticals Market Trends |
6 Indonesia Pharmaceuticals Market, By Types |
6.1 Indonesia Pharmaceuticals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Pharmaceuticals Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Indonesia Pharmaceuticals Market Revenues & Volume, By Pharmaceutical Drugs, 2021-2031F |
6.1.4 Indonesia Pharmaceuticals Market Revenues & Volume, By Biologics, 2021-2031F |
6.2 Indonesia Pharmaceuticals Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Pharmaceuticals Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.2.3 Indonesia Pharmaceuticals Market Revenues & Volume, By Retail Pharmacies/ Drug Stores, 2021-2031F |
6.2.4 Indonesia Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.3 Indonesia Pharmaceuticals Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Pharmaceuticals Market Revenues & Volume, By Oral, 2021-2031F |
6.3.3 Indonesia Pharmaceuticals Market Revenues & Volume, By Parenteral, 2021-2031F |
6.3.4 Indonesia Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.4 Indonesia Pharmaceuticals Market, By Drug Classification |
6.4.1 Overview and Analysis |
6.4.2 Indonesia Pharmaceuticals Market Revenues & Volume, By Branded Drugs, 2021-2031F |
6.4.3 Indonesia Pharmaceuticals Market Revenues & Volume, By Generic Drugs, 2021-2031F |
6.5 Indonesia Pharmaceuticals Market, By Mode of Purchase |
6.5.1 Overview and Analysis |
6.5.2 Indonesia Pharmaceuticals Market Revenues & Volume, By Prescription-Based Drugs, 2021-2031F |
6.5.3 Indonesia Pharmaceuticals Market Revenues & Volume, By Over-The-Counter Drugs, 2021-2031F |
7 Indonesia Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Indonesia Pharmaceuticals Market Export to Major Countries |
7.2 Indonesia Pharmaceuticals Market Imports from Major Countries |
8 Indonesia Pharmaceuticals Market Key Performance Indicators |
9 Indonesia Pharmaceuticals Market - Opportunity Assessment |
9.1 Indonesia Pharmaceuticals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Indonesia Pharmaceuticals Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 Indonesia Pharmaceuticals Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Indonesia Pharmaceuticals Market Opportunity Assessment, By Drug Classification, 2021 & 2031F |
9.5 Indonesia Pharmaceuticals Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
10 Indonesia Pharmaceuticals Market - Competitive Landscape |
10.1 Indonesia Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |